Silverback Therapeutics (SBTX) Short Interest Ratio & Short Volume → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free SBTX Stock Alerts $8.35 +0.26 (+3.21%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsFinancialsInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsInsider TradesOwnershipSEC FilingsSocial Media Silverback Therapeutics Short Interest DataCurrent Short Volume897,600 sharesPrevious Short Volume996,600 sharesChange Vs. Previous Month-9.93%Dollar Volume Sold Short$4.70 millionShort Interest Ratio / Days to Cover3.8Last Record DateOctober 15, 2022Outstanding Shares36,058,000 sharesFloat Size24,290,000 sharesShort Percent of Float3.70%Today's Trading Volume520,296 sharesAverage Trading Volume337,931 sharesToday's Volume Vs. Average154% Short Selling Silverback Therapeutics ? Sign up to receive the latest short interest report for Silverback Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSBTX Short Interest Over TimeSBTX Days to Cover Over TimeSBTX Percentage of Float Shorted Over Time Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details Silverback Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/2022897,600 shares $4.70 million -9.9%3.7%3.8 $5.24 9/30/2022996,600 shares $5.26 million +83.5%4.1%3.6 $5.28 9/15/2022543,000 shares $2.76 million +0.6%2.3%1.6 $5.08 8/31/2022539,700 shares $2.94 million +5.3%2.3%1.4 $5.44 8/15/2022512,400 shares $2.66 million -0.3%2.1%1.2 $5.20 7/31/2022513,900 shares $2.65 million -7.2%2.2%1.1 $5.16 Get the Latest News and Ratings for SBTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Silverback Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/15/2022553,900 shares $2.44 million -28.2%2.3%1.3 $4.41 6/30/2022771,200 shares $3.27 million -32.4%3.2%1.8 $4.24 6/15/20221,140,000 shares $4.57 million +7.6%5.6%2.4 $4.01 5/31/20221,060,000 shares $3.70 million -16.5%5.2%2.6 $3.49 5/15/20221,270,000 shares $3.76 million +5.0%6.2%3.2 $2.96 4/30/20221,210,000 shares $3.76 million +35.2%5.9%3.1 $3.11 4/15/2022895,100 shares $2.87 million +35.1%4.3%2.3 $3.21 3/31/2022662,700 shares $2.33 million -24.9%3.2%1.8 $3.51 3/15/2022882,300 shares $3.31 million -46.2%4.3%2.9 $3.75 2/28/20221,640,000 shares $7.05 million -0.6%8.0%5 $4.30 2/15/20221,650,000 shares $7.29 million No Change8.0%4.4 $4.42 1/31/20221,650,000 shares $8.04 million +1.9%8.7%4.2 $4.87 1/15/20221,620,000 shares $7.95 million +3.2%9.8%4 $4.91 12/31/20211,570,000 shares $10.46 million -18.2%9.5%3.8 $6.66 12/15/20211,920,000 shares $12.63 million -12.7%11.6%4.3 $6.58 11/30/20212,200,000 shares $15.47 million -46.0%13.3%4.2 $7.03 11/15/20214,070,000 shares $35.37 million +4.9%24.6%8 $8.69 10/29/20213,880,000 shares $33.48 million -2.0%23.4%8.2 $8.63 10/15/20213,960,000 shares $39.05 million -1.7%23.9%9.2 $9.86 9/30/20214,030,000 shares $40.22 million +10.1%24.3%10.7 $9.98 9/15/20213,660,000 shares $59.48 million +11.9%22.1%11.7 $16.25 8/31/20213,270,000 shares $71.94 million +0.9%19.8%16.9 $22.00 8/13/20213,240,000 shares $93.90 million +0.9%19.6%25.4 $28.98 7/30/20213,210,000 shares $97.20 million +5.3%19.5%26.2 $30.28 7/15/20213,050,000 shares $91.53 million -4.4%12.1%22.7 $30.01 6/30/20213,190,000 shares $98.54 million -3.9%12.7%23 $30.89 6/15/20213,320,000 shares $107.83 million +4.1%13.2%24.1 $32.48 5/28/20213,190,000 shares $87.82 million -0.9%12.7%16 $27.53 5/14/20213,220,000 shares $79.57 million +4.9%12.8%15.2 $24.71 4/30/20213,070,000 shares $104.50 million +8.9%12.2%13.4 $34.04 4/15/20212,820,000 shares $107.98 million -6.3%11.2%12.2 $38.29 3/31/20213,010,000 shares $122.12 million +20.4%12.0%12.9 $40.57 3/15/20212,500,000 shares $138.78 million +15.2%10.0%10.1 $55.51 2/26/20212,170,000 shares $107.63 million +29.9%8.7%8.2 $49.60These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy SBTX Short Interest - Frequently Asked Questions What is Silverback Therapeutics' current short interest? Short interest is the volume of Silverback Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 897,600 shares of SBTX short. 3.70% of Silverback Therapeutics' shares are currently sold short. Learn More on Silverback Therapeutics' current short interest. What is a good short interest ratio for Silverback Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SBTX shares currently have a short interest ratio of 4.0. Learn More on Silverback Therapeutics's short interest ratio. What is a good short interest percentage for Silverback Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.70% of Silverback Therapeutics' floating shares are currently sold short. Is Silverback Therapeutics' short interest increasing or decreasing? Silverback Therapeutics saw a drop in short interest in October. As of October 15th, there was short interest totaling 897,600 shares, a drop of 9.9% from the previous total of 996,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Silverback Therapeutics' float size? Silverback Therapeutics currently has issued a total of 36,058,000 shares. Some of Silverback Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Silverback Therapeutics currently has a public float of 24,290,000 shares. How does Silverback Therapeutics' short interest compare to its competitors? 3.70% of Silverback Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Silverback Therapeutics: Ventyx Biosciences, Inc. (17.54%), XOMA Co. (2.42%), Terns Pharmaceuticals, Inc. (10.70%), Aquestive Therapeutics, Inc. (5.47%), Atea Pharmaceuticals, Inc. (2.37%), CorMedix Inc. (17.11%), Kamada Ltd. (0.12%), Neoleukin Therapeutics, Inc. (0.35%), Erasca, Inc. (10.56%), Verrica Pharmaceuticals Inc. (15.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.48 billion), Charter Communications, Inc. ($2.85 billion), Twitter, Inc. ($1.89 billion), T. Rowe Price Group, Inc. ($1.78 billion), Coinbase Global, Inc. ($1.77 billion), PG&E Co. ($1.75 billion), Lucid Group, Inc. ($1.58 billion), Rivian Automotive, Inc. ($1.42 billion), Roblox Co. ($1.39 billion), and Williams-Sonoma, Inc. ($1.33 billion). View all of the most shorted stocks. What does it mean to sell short Silverback Therapeutics stock? Short selling SBTX is an investing strategy that aims to generate trading profit from Silverback Therapeutics as its price is falling. SBTX shares are trading up $0.26 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Silverback Therapeutics? A short squeeze for Silverback Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SBTX, which in turn drives the price of the stock up even further. How often is Silverback Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SBTX, twice per month. The most recent reporting period available is October, 15 2022. More Short Interest Resources from MarketBeat Related Companies: Ventyx Biosciences Short Interest XOMA Short Interest Terns Pharmaceuticals Short Interest Aquestive Therapeutics Short Interest Atea Pharmaceuticals Short Interest CorMedix Short Interest Kamada Short Interest Neoleukin Therapeutics Short Interest Erasca Short Interest Verrica Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SBTX) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics